Dr. Perl Discusses the Impact of CAR T-Cell Therapy on ALL
February 16th 2018Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses the impact of chimeric antigen receptor (CAR) T-cell therapy on the treatment of patients with acute lymphoblastic leukemia (ALL).
Read More